Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Telephone And Data Systems VV Pref | TDS-V | Jan 10, 2025 | 18.13 | -1.49 |
Telesat | TSAT | Jan 10, 2025 | 16.26 | -5.13 |
Telix Pharmaceuticals | TLX | Jan 10, 2025 | 14.63 | 0.00 |
Telomir Pharmaceuticals | TELO | Jan 10, 2025 | 4.11 | -4.42 |
Telos | TLS | Jan 10, 2025 | 3.19 | +0.63 |
Telus | TU | Jan 10, 2025 | 13.64 | -1.87 |
Telus International | TIXT | Jan 10, 2025 | 3.22 | +0.63 |
Tempest Therapeutics | TPST | Jan 10, 2025 | 0.95 | -3.67 |
Templeton Dragon Fund | TDF | Jan 10, 2025 | 8.11 | -2.05 |
Templeton Emerging Markets | TEI | Jan 10, 2025 | 5.20 | 0.00 |
Templeton Emerging Markets Fund | EMF | Jan 10, 2025 | 11.80 | -1.75 |
Tempur Sealy International | TPX | Jan 10, 2025 | 55.14 | +0.04 |
Tempus AI | TEM | Jan 10, 2025 | 37.52 | +0.08 |
Tenable | TENB | Jan 10, 2025 | 38.49 | -1.03 |
Tenaris ADR | TS | Jan 10, 2025 | 38.43 | -0.90 |
Tenax Therapeutics | TENX | Jan 10, 2025 | 6.24 | -3.70 |
Tenaya Therapeutics | TNYA | Jan 10, 2025 | 1.46 | +2.82 |
Tencent Music Entertainment A ADR | TME | Jan 10, 2025 | 10.74 | -1.65 |
Tenet Healthcare | THC | Jan 10, 2025 | 127.97 | -1.72 |
Tennant | TNC | Jan 10, 2025 | 79.73 | -0.35 |
Tennessee Valley Authority C Pref | TVC | Jan 10, 2025 | 22.74 | +0.04 |
Tennessee Valley Authority E Pref | TVE | Jan 10, 2025 | 22.30 | -0.09 |
Tenon Medical | TNON | Jan 10, 2025 | 1.84 | -0.54 |
Teradata | TDC | Jan 10, 2025 | 30.32 | -2.57 |
Teradyne | TER | Jan 10, 2025 | 134.17 | -2.17 |
TeraWulf | WULF | Jan 10, 2025 | 5.40 | -2.00 |
Terex | TEX | Jan 10, 2025 | 43.99 | -2.09 |
Ternium ADR | TX | Jan 10, 2025 | 28.55 | -1.48 |
Terns Pharmaceuticals | TERN | Jan 10, 2025 | 5.01 | -4.48 |
Terreno Realty | TRNO | Jan 10, 2025 | 57.92 | -1.01 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.